Allergan’s quarterly profit beats Wall Street estimates

Allergan reported a better-than-expected quarterly profit, helped by strength in its medical aesthetics unit, prompting the company to raise its full-year revenue forecast. It now expects full-year revenue in the range of $15.85bn (£12.33bn) to $16.05bn (£12.48bn) from its previous forecast of $15.80bn (£12.29 bn) to $16bn (£12.44bn). Net revenue for the quarter rose 9% to $4.01bn (£3.12bn), beating Wall Street estimates of $3.94bn (£3.06bn).